Expression of metallothionein II in intestinal metaplasia, dysplasia, and gastric cancer

Matthias P A Ebert, Thomas Günther, Juliane Hoffmann, Jun Yu, Stephan Miehlke, Hans U. Schulz, Albert Roessner, Murray Korc, Peter Malfertheiner

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Differential display is a valuable tool for the identification of differentially expressed genes in human carcinogenesis and development. The search for differentially expressed genes in gastric cancer and its premalignant lesions may help to define molecular alterations in the gastric mucosa that may precede the development of gastric cancer. Using the differential display technique, we identified a cDNA fragment, encoding metallothionein (MT) Ha mRNA. We performed immunohistochemical analysis using a monoclonal antibody directed against human MT and tissues obtained from 34 patients with gastric cancer and 20 healthy individuals to determine the expression and localization of MT in gastric cancer and its associated premalignant lesions and to correlate our findings with histomorphological features and Helicobacter pylori status. In addition, MT expression was assessed in gastric tissues obtained from patients with gastric cancer and first-degree relatives of patients with gastric cancers and healthy individuals using reverse transcription-PCR analysis. Northern blot analysis confirmed the overexpression of MT IIa in gastric cancer. In the normal gastric tissues, no MT immunoreactivity was observed at the superficial gastric epithelium toward the top of gastric glands. However, MT immunoreactivity was detected at the foveolar neck of the gastric glands. Immunohistochemical analysis revealed an intense MT immunoreactivity in gastric cancer cells, independent of tumor stage, grade of differentiation, or tumor type. Furthermore, areas of dysplasia and intestinal metaplasia also exhibited intense MT immunoreactivity. Reverse transcription-PCR analysis of gastric biopsies obtained from first-degree relatives of patients with gastric cancer revealed the frequent expression of MT Ia in this high-risk group as compared with healthy subjects (P <0.01). The overexpression of MT in gastric cancer and the expression of MT in intestinal metaplasia and dysplasia, as well as the expression of MT in the gastric mucosa of first- degree relatives of patients with gastric cancer, point to a role for MT in the early process of malignant transformation of the gastric mucosa.

Original languageEnglish (US)
Pages (from-to)1995-2001
Number of pages7
JournalCancer Research
Volume60
Issue number7
StatePublished - Apr 1 2000
Externally publishedYes

Fingerprint

Metallothionein
Metaplasia
Stomach Neoplasms
Gastric Mucosa
Stomach
Reverse Transcription
Polymerase Chain Reaction
Human Development
Helicobacter pylori
Northern Blotting
Genes
Neoplasms
Healthy Volunteers
Carcinogenesis

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Ebert, M. P. A., Günther, T., Hoffmann, J., Yu, J., Miehlke, S., Schulz, H. U., ... Malfertheiner, P. (2000). Expression of metallothionein II in intestinal metaplasia, dysplasia, and gastric cancer. Cancer Research, 60(7), 1995-2001.

Expression of metallothionein II in intestinal metaplasia, dysplasia, and gastric cancer. / Ebert, Matthias P A; Günther, Thomas; Hoffmann, Juliane; Yu, Jun; Miehlke, Stephan; Schulz, Hans U.; Roessner, Albert; Korc, Murray; Malfertheiner, Peter.

In: Cancer Research, Vol. 60, No. 7, 01.04.2000, p. 1995-2001.

Research output: Contribution to journalArticle

Ebert, MPA, Günther, T, Hoffmann, J, Yu, J, Miehlke, S, Schulz, HU, Roessner, A, Korc, M & Malfertheiner, P 2000, 'Expression of metallothionein II in intestinal metaplasia, dysplasia, and gastric cancer', Cancer Research, vol. 60, no. 7, pp. 1995-2001.
Ebert MPA, Günther T, Hoffmann J, Yu J, Miehlke S, Schulz HU et al. Expression of metallothionein II in intestinal metaplasia, dysplasia, and gastric cancer. Cancer Research. 2000 Apr 1;60(7):1995-2001.
Ebert, Matthias P A ; Günther, Thomas ; Hoffmann, Juliane ; Yu, Jun ; Miehlke, Stephan ; Schulz, Hans U. ; Roessner, Albert ; Korc, Murray ; Malfertheiner, Peter. / Expression of metallothionein II in intestinal metaplasia, dysplasia, and gastric cancer. In: Cancer Research. 2000 ; Vol. 60, No. 7. pp. 1995-2001.
@article{c382ff38a5694b86b8d7a39991ad83c2,
title = "Expression of metallothionein II in intestinal metaplasia, dysplasia, and gastric cancer",
abstract = "Differential display is a valuable tool for the identification of differentially expressed genes in human carcinogenesis and development. The search for differentially expressed genes in gastric cancer and its premalignant lesions may help to define molecular alterations in the gastric mucosa that may precede the development of gastric cancer. Using the differential display technique, we identified a cDNA fragment, encoding metallothionein (MT) Ha mRNA. We performed immunohistochemical analysis using a monoclonal antibody directed against human MT and tissues obtained from 34 patients with gastric cancer and 20 healthy individuals to determine the expression and localization of MT in gastric cancer and its associated premalignant lesions and to correlate our findings with histomorphological features and Helicobacter pylori status. In addition, MT expression was assessed in gastric tissues obtained from patients with gastric cancer and first-degree relatives of patients with gastric cancers and healthy individuals using reverse transcription-PCR analysis. Northern blot analysis confirmed the overexpression of MT IIa in gastric cancer. In the normal gastric tissues, no MT immunoreactivity was observed at the superficial gastric epithelium toward the top of gastric glands. However, MT immunoreactivity was detected at the foveolar neck of the gastric glands. Immunohistochemical analysis revealed an intense MT immunoreactivity in gastric cancer cells, independent of tumor stage, grade of differentiation, or tumor type. Furthermore, areas of dysplasia and intestinal metaplasia also exhibited intense MT immunoreactivity. Reverse transcription-PCR analysis of gastric biopsies obtained from first-degree relatives of patients with gastric cancer revealed the frequent expression of MT Ia in this high-risk group as compared with healthy subjects (P <0.01). The overexpression of MT in gastric cancer and the expression of MT in intestinal metaplasia and dysplasia, as well as the expression of MT in the gastric mucosa of first- degree relatives of patients with gastric cancer, point to a role for MT in the early process of malignant transformation of the gastric mucosa.",
author = "Ebert, {Matthias P A} and Thomas G{\"u}nther and Juliane Hoffmann and Jun Yu and Stephan Miehlke and Schulz, {Hans U.} and Albert Roessner and Murray Korc and Peter Malfertheiner",
year = "2000",
month = "4",
day = "1",
language = "English (US)",
volume = "60",
pages = "1995--2001",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "7",

}

TY - JOUR

T1 - Expression of metallothionein II in intestinal metaplasia, dysplasia, and gastric cancer

AU - Ebert, Matthias P A

AU - Günther, Thomas

AU - Hoffmann, Juliane

AU - Yu, Jun

AU - Miehlke, Stephan

AU - Schulz, Hans U.

AU - Roessner, Albert

AU - Korc, Murray

AU - Malfertheiner, Peter

PY - 2000/4/1

Y1 - 2000/4/1

N2 - Differential display is a valuable tool for the identification of differentially expressed genes in human carcinogenesis and development. The search for differentially expressed genes in gastric cancer and its premalignant lesions may help to define molecular alterations in the gastric mucosa that may precede the development of gastric cancer. Using the differential display technique, we identified a cDNA fragment, encoding metallothionein (MT) Ha mRNA. We performed immunohistochemical analysis using a monoclonal antibody directed against human MT and tissues obtained from 34 patients with gastric cancer and 20 healthy individuals to determine the expression and localization of MT in gastric cancer and its associated premalignant lesions and to correlate our findings with histomorphological features and Helicobacter pylori status. In addition, MT expression was assessed in gastric tissues obtained from patients with gastric cancer and first-degree relatives of patients with gastric cancers and healthy individuals using reverse transcription-PCR analysis. Northern blot analysis confirmed the overexpression of MT IIa in gastric cancer. In the normal gastric tissues, no MT immunoreactivity was observed at the superficial gastric epithelium toward the top of gastric glands. However, MT immunoreactivity was detected at the foveolar neck of the gastric glands. Immunohistochemical analysis revealed an intense MT immunoreactivity in gastric cancer cells, independent of tumor stage, grade of differentiation, or tumor type. Furthermore, areas of dysplasia and intestinal metaplasia also exhibited intense MT immunoreactivity. Reverse transcription-PCR analysis of gastric biopsies obtained from first-degree relatives of patients with gastric cancer revealed the frequent expression of MT Ia in this high-risk group as compared with healthy subjects (P <0.01). The overexpression of MT in gastric cancer and the expression of MT in intestinal metaplasia and dysplasia, as well as the expression of MT in the gastric mucosa of first- degree relatives of patients with gastric cancer, point to a role for MT in the early process of malignant transformation of the gastric mucosa.

AB - Differential display is a valuable tool for the identification of differentially expressed genes in human carcinogenesis and development. The search for differentially expressed genes in gastric cancer and its premalignant lesions may help to define molecular alterations in the gastric mucosa that may precede the development of gastric cancer. Using the differential display technique, we identified a cDNA fragment, encoding metallothionein (MT) Ha mRNA. We performed immunohistochemical analysis using a monoclonal antibody directed against human MT and tissues obtained from 34 patients with gastric cancer and 20 healthy individuals to determine the expression and localization of MT in gastric cancer and its associated premalignant lesions and to correlate our findings with histomorphological features and Helicobacter pylori status. In addition, MT expression was assessed in gastric tissues obtained from patients with gastric cancer and first-degree relatives of patients with gastric cancers and healthy individuals using reverse transcription-PCR analysis. Northern blot analysis confirmed the overexpression of MT IIa in gastric cancer. In the normal gastric tissues, no MT immunoreactivity was observed at the superficial gastric epithelium toward the top of gastric glands. However, MT immunoreactivity was detected at the foveolar neck of the gastric glands. Immunohistochemical analysis revealed an intense MT immunoreactivity in gastric cancer cells, independent of tumor stage, grade of differentiation, or tumor type. Furthermore, areas of dysplasia and intestinal metaplasia also exhibited intense MT immunoreactivity. Reverse transcription-PCR analysis of gastric biopsies obtained from first-degree relatives of patients with gastric cancer revealed the frequent expression of MT Ia in this high-risk group as compared with healthy subjects (P <0.01). The overexpression of MT in gastric cancer and the expression of MT in intestinal metaplasia and dysplasia, as well as the expression of MT in the gastric mucosa of first- degree relatives of patients with gastric cancer, point to a role for MT in the early process of malignant transformation of the gastric mucosa.

UR - http://www.scopus.com/inward/record.url?scp=0343674631&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0343674631&partnerID=8YFLogxK

M3 - Article

C2 - 10766190

AN - SCOPUS:0343674631

VL - 60

SP - 1995

EP - 2001

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 7

ER -